Drug recall · October 17, 2018
Glipizide XL recall
Why: CGMP Deviations; rejected product was used to manufacture final bulk lot
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2
- Lots / codes
Lot: T71137 Exp. Feb. 2022
- Quantity
- 7777 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide
- Initiated
- September 20, 2018 · Voluntary: Firm initiated
- Classified
- October 9, 2018
- Reported
- October 17, 2018
- Ended
- May 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glipizide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.